Market reports related to the healthcare industry has been presented by Market Research
Future, which states that the global autoimmune disease treatment market is anticipated to
surge at a CAGR of 11.2% during the forecast period of 2017-2023.
Request Sample Copy:
The developments and innovations have increased the quality of medication in the latest era,
thereby increasing the demand for treatments for various diseases, where autoimmune disease
also stands firmly. This disease is a condition where the immune system of a body destroys its
body tissue. As per the reports, there are approximately 80 different types of autoimmune
disorders, but among those, multiple sclerosis, IBD, diabetes, rheumatoid arthritis, psoriasis,
and more are the standard versions. This disease can eventually result in abnormal growth of
an organ, destruction of body tissue, and changes in the function of the organ. According to the
National Institutes of Health (NIH), it was reported that around 23.5 million Americans are
suffering from autoimmune disease. NIH also stated in the reports that the annual direct health
care costs for autoimmune disease are near about USD 100 billion. Apart from this, even
cancers and heart & strokes cost around USD 57 billion, and USD 200 billion respectively.
Market Drivers & Trends
Emphasis on the increasing prevalence of autoimmune diseases has increased the level of
demand for autoimmune disease treatment. Though growing public awareness has increased
the development potential of the market during the forecast period. Government and other
private associations have also started educating people about diseases through conducting
seminars and conferences.
On the other hand, technological advancements, unmet medical needs, increasing government
assistance, rising prevalence of co-existing disorders, improving regulatory framework are the
prime factors contributing remarkably to the global autoimmune d